In vivo activity of dihydroartemisinin against schistosoma mansoni schistosomula in mice

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 44, Issue 3, 2013, Pages 379-387

  Li, Hong Jun ^a,b   Wang, Wei ^a   Li, You Zi ^a   Qu, Guo Li ^a   Xing, Yun Tian ^a   Qian, Ke ^a   Jia, Yue ^a   Yang, Zhen Kun ^a   Qian, Yi Li ^a   Dai, Jian Rong ^a   Liang, You Sheng ^a  

^a BEIJING HOSPITAL   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Dihydroartemisinin; Genital system; In vivo effect; Mice; Schistosoma mansoni; Schistosomula

Indexed keywords

EID: 84882587171     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Amsden AF, Boros DL, Hood AT. Etiology of the liver granulomatous response in Schistosoma mansoni-mfected athymic nude mice. Infect Immun 1980; 27: 75-80.
2. Boros DL. Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev 1989; 2: 250-69.
3. Doenhoff MJ, Cioli D, Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 2008; 21: 659-67.
4. Fallon PG, Doenhoff MJ. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am Trop Med Hyg 1994; 51: 83-8.
5. Fallon PG, Sturrock RF, Niang AC, Doenhoff MJ. Diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg 1995; 53:61-2.
6. Huang YX, Xiao SH. Praziquantel, an anthelmintic drug: research and application. Beijing: People's Medical Publishing House, 2008.
7. Ismail M, Metwally A, Farghaly A, Bruce J, Tao LF, Bennett JL. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high dose of praziquantel. Am Trop Med Hyg 1996; 55: 214-8.
8. Li HJ, Wang W, Liang YS. Advances in research of dihydroartemisinin against parasitic diseases. Chin J Schisto Control 2011a; 23: 460-4.
9. Li HJ, Wang W, Li YZ, et al. Effects of artemether, artesunate and dihydroartemisinin ad-ministered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum. Parasitol Res 2011b; 109: 515-9.
10. Li HJ, Wang W, Qu GL, et al. In-vivo activity of dihydroartemisinin against Schistosoma japonicum. Ann Trop Med Parasitol 2011c; 105:181-5.
11. Li HJ, Wang W, Qu GL, et al. Dihydroarte- misinin-praziquantel combinations and multiple doses of dihydroartemisinin in the treatment of Schistosoma japonicum in experimentally infected mice. Ann Trop Med Parasitol 2011d; 105:329-33.
12. Li HJ, Wang W, Qu GL, et al. Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice. Parasitol Res 2012; 110:1725-32.
13. Li YS. Pathology technology. Beijing: People's Medical Publishing House, 2000.
14. Mao SB. Biology of Schistosoma and schistoso miasis control. Beijing: People's Medical Publishing House, 1990.
15. Melman SD, Steinauer ML, Cunningham C, et al. Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PloS Negl Trop Dis 2009; 3: e504.
16. Sadun EH, Williams JS, Witherspoon C, Martin LK. The relative role of eggs and adult worms in the development of liver damage in mice infected with Schistosoma mansoni. Ann NY Acad Sci 1969; 160: 841-62.
17. Smithers SR, Terry RJ. The infection of laboratory hosts with cercariae of Schistosoma mansoni and recovery of adult worms. Parasitology 1965; 55: 695-700.
18. Stelma FF, Talla I, Sow S, et al. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am Trop Med Hyg 1995; 53:167-70.
19. Utzinger J, Chollet J, You J, Mei J, Tanner M, Xiao SH. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals. Acta Trop 2001; 80: 9-18.
20. Utzinger J, Chollet J, Tu Z, Xiao SH, Tanner M. Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice. Trans R Soc Trop Med Hyg 2002; 96: 318-23.
21. Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Xiao SH, Tanner M. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 2000; 355:1320-5.
22. Van de Vijver KK, Deelder AM, Jacobs W, Van Marck EA, Hokke CH. LacdiNAc- and LacNAc-containing glycans induce granulomas in an in vivo model for schistosome egg-induced hepatic granuloma formation. Glycobiology 2006; 16: 237-43.
23. Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev 2004; 201: 156-67.
24. Xiao SH, Booth M, Tanner M. The prophylactic effects of artemether against Schistosoma japonicum infections. Parasitol Today 2000b; 16:122-6.
25. Xiao SH, Chollet J, Weiss NA, Bergquist RN, Tanner M. Preventive effect of artemether in experimental animals infected with Schistosoma mansoni. Parasitol lnt 2000a; 49:19-24.
26. Xiao SH, Guo J, Chollet J, Wu JT, Tanner M, Utzinger J. Effect of artemether on Schistosoma mansoni: dose-efficacy relationship, and changes in worm morphology and histopathology. Chin Parasitol Parasit Dis 2004; 22:148-53.
27. Xiao SH, You JQ, Gao HF, et al. Schistosoma japonicum: effect of artemether on glutathione S-transferase and superoxide dismutase. Exp Parasitol 2002b; 102:38-45.
28. Xiao SH, You JQ, Yang YQ, Wang CZ. Experimental studies on early treatment of schistosomal infection with artemether. Southeast Asian J Trop Med Public Health 1995; 26: 306-8.
29. Xiao SH, Utzinger J, Chollet J, Tanner M. Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both, lnt Parasitol 2006; 36: 957-64.